SlideShare a Scribd company logo
1 of 1
Download to read offline
Prediction of Gene Signatures in TGFB-induced
Breast Cancer Metastasis by Markov Chain Model
Yang Cong, Shenyi Chen, Stephen T.C. Wong
Department of Systems Medicine and Bioengineering, Houston Methodist Research Institute, 6670 Berter Ave, Houston, TX 77030
Abstract
Introduction
TGFB-EMT pathway
CDH1 transcription factor selection
Expression Signature Prediction
Results
Acknowledgements
•NCI Center for Modeling Cancer Development U54 Ca149196
Metastasis is a major cause of patient death in breast cancer.
Epithelial-mesenchymal transition (EMT) plays the initiation
role in the metastasis cascade. Based on gene profiling data
of 1165 breast cancer patients in TCGA, we built a statistical
Markov Chain model to predict gene signatures of epithelial
and mesenchymal cells. Based on the literature integrated
TGFB-induced EMT pathway, we extracted the regulatory
mechanism among molecules. We used a recursive
algorithm to predict the likelihood of expression signatures
and further mapped the prediction with known epithelial
and mesenchymal expression patterns.
A molecule is regulated by its regulators, and the change of its
expression level only depends on the observed expression of
all its regulators
The loss of the epithelial adhesion molecule E-cadherin
(CDH1) is considered as a fundamental event in EMT and an
early step in cancer metastasis. EMT can be induced by
several growth factors, such as TGFB1, hepatocyte growth
factor, and platelet-derived growth factor PDGF. Also EMT
can be induced by any one of the following transcription
factors alone, such as SNAI1, SNAI2, TWIST1, FOXC1, FOXC2,
ZEB1 and ZEB2.
A central target of these transcription factors listed above is
the repression of E-cadherin gene CDH1. The expression level
of CDH1 plays a key role in the cell phenotype. The inhibition
of CDH1 expression is the starter of EMT process. Epithelial
cells have a high expression level of CDH1, meanwhile
mesenchymal cells have a low expression. Hence, we map the
expression patterns with cell types based on the expression
level of CDH1.
Data Processing

More Related Content

What's hot

SCT60103 - Chemotherapy
SCT60103 - Chemotherapy SCT60103 - Chemotherapy
SCT60103 - Chemotherapy KaiXuan Lim
 
Level of Tumor Protein Indicates Chances Cancer Will Spread and Structural De...
Level of Tumor Protein Indicates Chances Cancer Will Spread and Structural De...Level of Tumor Protein Indicates Chances Cancer Will Spread and Structural De...
Level of Tumor Protein Indicates Chances Cancer Will Spread and Structural De...karito04_15
 
Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migratio...
Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migratio...Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migratio...
Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migratio...Enrique Moreno Gonzalez
 
Vol 87-no2-article-3
Vol 87-no2-article-3Vol 87-no2-article-3
Vol 87-no2-article-3Rakesh Kumar
 
SCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationSCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationJayden On
 
Differentiation of triple-negative breast cancer - BioGenex
Differentiation of triple-negative breast cancer - BioGenexDifferentiation of triple-negative breast cancer - BioGenex
Differentiation of triple-negative breast cancer - BioGenexVictoria Miller
 
Immuotherapy 2
Immuotherapy 2Immuotherapy 2
Immuotherapy 2drmcbansal
 
stem cell poster final
stem cell poster finalstem cell poster final
stem cell poster finalKhushbu Bhatt
 
Central dogma of genetic information
Central dogma of genetic informationCentral dogma of genetic information
Central dogma of genetic informationDaniel Vanegas
 
Rectal cancer
Rectal cancerRectal cancer
Rectal cancerSpringer
 
Thesis-Final Draft
Thesis-Final DraftThesis-Final Draft
Thesis-Final DraftEmer Shelly
 
Charles Okechukwu-Poster Presentation.
Charles Okechukwu-Poster Presentation.Charles Okechukwu-Poster Presentation.
Charles Okechukwu-Poster Presentation.Charles Okechukwu
 
Immunotherapy in endometrial
Immunotherapy in endometrialImmunotherapy in endometrial
Immunotherapy in endometrialOrmias Pratama
 
Correlation between circulating and tumour tissue CCL5 and TGFβ1 in breast ca...
Correlation between circulating and tumour tissue CCL5 and TGFβ1 in breast ca...Correlation between circulating and tumour tissue CCL5 and TGFβ1 in breast ca...
Correlation between circulating and tumour tissue CCL5 and TGFβ1 in breast ca...Marion Hartmann
 

What's hot (20)

SCT60103 - Chemotherapy
SCT60103 - Chemotherapy SCT60103 - Chemotherapy
SCT60103 - Chemotherapy
 
Gtc presentation
Gtc presentationGtc presentation
Gtc presentation
 
Level of Tumor Protein Indicates Chances Cancer Will Spread and Structural De...
Level of Tumor Protein Indicates Chances Cancer Will Spread and Structural De...Level of Tumor Protein Indicates Chances Cancer Will Spread and Structural De...
Level of Tumor Protein Indicates Chances Cancer Will Spread and Structural De...
 
Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migratio...
Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migratio...Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migratio...
Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migratio...
 
Vol 87-no2-article-3
Vol 87-no2-article-3Vol 87-no2-article-3
Vol 87-no2-article-3
 
SCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationSCT60103 Group 2 Presentation
SCT60103 Group 2 Presentation
 
Differentiation of triple-negative breast cancer - BioGenex
Differentiation of triple-negative breast cancer - BioGenexDifferentiation of triple-negative breast cancer - BioGenex
Differentiation of triple-negative breast cancer - BioGenex
 
Diploma Thesis - Abstract
Diploma Thesis - AbstractDiploma Thesis - Abstract
Diploma Thesis - Abstract
 
Immuotherapy 2
Immuotherapy 2Immuotherapy 2
Immuotherapy 2
 
stem cell poster final
stem cell poster finalstem cell poster final
stem cell poster final
 
Central dogma of genetic information
Central dogma of genetic informationCentral dogma of genetic information
Central dogma of genetic information
 
Rectal cancer
Rectal cancerRectal cancer
Rectal cancer
 
Thesis-Final Draft
Thesis-Final DraftThesis-Final Draft
Thesis-Final Draft
 
Publication NJEM (2015)
Publication NJEM (2015)Publication NJEM (2015)
Publication NJEM (2015)
 
Charles Okechukwu-Poster Presentation.
Charles Okechukwu-Poster Presentation.Charles Okechukwu-Poster Presentation.
Charles Okechukwu-Poster Presentation.
 
Smyd3
Smyd3Smyd3
Smyd3
 
MasterThesis
MasterThesisMasterThesis
MasterThesis
 
Immunotherapy in endometrial
Immunotherapy in endometrialImmunotherapy in endometrial
Immunotherapy in endometrial
 
Correlation between circulating and tumour tissue CCL5 and TGFβ1 in breast ca...
Correlation between circulating and tumour tissue CCL5 and TGFβ1 in breast ca...Correlation between circulating and tumour tissue CCL5 and TGFβ1 in breast ca...
Correlation between circulating and tumour tissue CCL5 and TGFβ1 in breast ca...
 
P1-01-17_poster
P1-01-17_posterP1-01-17_poster
P1-01-17_poster
 

Viewers also liked

Full page photo
Full page photoFull page photo
Full page photoYang Cong
 
PREGNANCY ASSOCIATED BREAST CANCER
PREGNANCY ASSOCIATED BREAST CANCERPREGNANCY ASSOCIATED BREAST CANCER
PREGNANCY ASSOCIATED BREAST CANCERsnowhiteheart
 
CU_zahidullah_original (1) (1) (2) (1) (1)
CU_zahidullah_original (1) (1) (2) (1) (1)CU_zahidullah_original (1) (1) (2) (1) (1)
CU_zahidullah_original (1) (1) (2) (1) (1)zahid ullah
 
INVESTIGATIONS AND THE TRIAL PROCEDURE IN UGANDA 2
INVESTIGATIONS AND THE TRIAL PROCEDURE IN UGANDA 2INVESTIGATIONS AND THE TRIAL PROCEDURE IN UGANDA 2
INVESTIGATIONS AND THE TRIAL PROCEDURE IN UGANDA 2Kakuru Joel
 
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...bkling
 
penjelasan tentang perangkat lunak
penjelasan tentang perangkat lunakpenjelasan tentang perangkat lunak
penjelasan tentang perangkat lunakJulmianti
 
Integral tak tentu dan tertentu i
Integral tak tentu dan tertentu iIntegral tak tentu dan tertentu i
Integral tak tentu dan tertentu irafsanjanistrong
 

Viewers also liked (11)

Full page photo
Full page photoFull page photo
Full page photo
 
PREGNANCY ASSOCIATED BREAST CANCER
PREGNANCY ASSOCIATED BREAST CANCERPREGNANCY ASSOCIATED BREAST CANCER
PREGNANCY ASSOCIATED BREAST CANCER
 
Bren edge waters
Bren edge watersBren edge waters
Bren edge waters
 
CU_zahidullah_original (1) (1) (2) (1) (1)
CU_zahidullah_original (1) (1) (2) (1) (1)CU_zahidullah_original (1) (1) (2) (1) (1)
CU_zahidullah_original (1) (1) (2) (1) (1)
 
JOCS COMPETÈNCIA ORAL
JOCS COMPETÈNCIA ORALJOCS COMPETÈNCIA ORAL
JOCS COMPETÈNCIA ORAL
 
Guia asistencial 2014 samu
Guia asistencial 2014 samuGuia asistencial 2014 samu
Guia asistencial 2014 samu
 
Fundación
FundaciónFundación
Fundación
 
INVESTIGATIONS AND THE TRIAL PROCEDURE IN UGANDA 2
INVESTIGATIONS AND THE TRIAL PROCEDURE IN UGANDA 2INVESTIGATIONS AND THE TRIAL PROCEDURE IN UGANDA 2
INVESTIGATIONS AND THE TRIAL PROCEDURE IN UGANDA 2
 
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
 
penjelasan tentang perangkat lunak
penjelasan tentang perangkat lunakpenjelasan tentang perangkat lunak
penjelasan tentang perangkat lunak
 
Integral tak tentu dan tertentu i
Integral tak tentu dan tertentu iIntegral tak tentu dan tertentu i
Integral tak tentu dan tertentu i
 

Similar to Yang Poster 2015

Hallmarks of cancer and radiopharmaceuticals
Hallmarks of cancer and radiopharmaceuticalsHallmarks of cancer and radiopharmaceuticals
Hallmarks of cancer and radiopharmaceuticalsAlice Viana
 
Poster_Template_Horizontal_Red
Poster_Template_Horizontal_RedPoster_Template_Horizontal_Red
Poster_Template_Horizontal_RedAlexander Seutin
 
ncomms8821-최종본
ncomms8821-최종본ncomms8821-최종본
ncomms8821-최종본Ryan Cho
 
Proteomics Exploration of Chronic Lymphocytic Leukemia_Crimson Publishers
Proteomics Exploration of Chronic Lymphocytic Leukemia_Crimson PublishersProteomics Exploration of Chronic Lymphocytic Leukemia_Crimson Publishers
Proteomics Exploration of Chronic Lymphocytic Leukemia_Crimson PublishersCrimsonpublishersCancer
 
Tumor suppressor
Tumor suppressorTumor suppressor
Tumor suppressorfatmafars
 
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...Mark Lipstein
 
Cancer epigenetics
Cancer epigeneticsCancer epigenetics
Cancer epigeneticsArad Boustan
 
Genetics of childhood solid tumors
Genetics of childhood solid tumorsGenetics of childhood solid tumors
Genetics of childhood solid tumorsBSMMU
 
Therapeutic strategies that target the cellular transformation process for ca...
Therapeutic strategies that target the cellular transformation process for ca...Therapeutic strategies that target the cellular transformation process for ca...
Therapeutic strategies that target the cellular transformation process for ca...JiaYiiChong
 
Project proposal from venkatesh (bt)
Project proposal from venkatesh (bt)Project proposal from venkatesh (bt)
Project proposal from venkatesh (bt)venkatesh naik
 
Molecular target therapy_in_colorectal_cancer[1]
Molecular target therapy_in_colorectal_cancer[1]Molecular target therapy_in_colorectal_cancer[1]
Molecular target therapy_in_colorectal_cancer[1]HebatAllah Bakri
 
Genetic Markers in AML
Genetic Markers in AMLGenetic Markers in AML
Genetic Markers in AMLFerdie Fatiga
 

Similar to Yang Poster 2015 (20)

Hallmarks of cancer and radiopharmaceuticals
Hallmarks of cancer and radiopharmaceuticalsHallmarks of cancer and radiopharmaceuticals
Hallmarks of cancer and radiopharmaceuticals
 
Poster_Template_Horizontal_Red
Poster_Template_Horizontal_RedPoster_Template_Horizontal_Red
Poster_Template_Horizontal_Red
 
ncomms8821-최종본
ncomms8821-최종본ncomms8821-최종본
ncomms8821-최종본
 
Proteomics Exploration of Chronic Lymphocytic Leukemia_Crimson Publishers
Proteomics Exploration of Chronic Lymphocytic Leukemia_Crimson PublishersProteomics Exploration of Chronic Lymphocytic Leukemia_Crimson Publishers
Proteomics Exploration of Chronic Lymphocytic Leukemia_Crimson Publishers
 
Natalia Cucu Simp 09
Natalia Cucu Simp 09Natalia Cucu Simp 09
Natalia Cucu Simp 09
 
Tumor suppressor
Tumor suppressorTumor suppressor
Tumor suppressor
 
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
 
Seminario biomol
Seminario biomolSeminario biomol
Seminario biomol
 
JCI0936541
JCI0936541JCI0936541
JCI0936541
 
Tumor Immunology
Tumor ImmunologyTumor Immunology
Tumor Immunology
 
Emt and ecm 2013
Emt and ecm 2013Emt and ecm 2013
Emt and ecm 2013
 
Cancer epigenetics
Cancer epigeneticsCancer epigenetics
Cancer epigenetics
 
Genetics of childhood solid tumors
Genetics of childhood solid tumorsGenetics of childhood solid tumors
Genetics of childhood solid tumors
 
Therapeutic strategies that target the cellular transformation process for ca...
Therapeutic strategies that target the cellular transformation process for ca...Therapeutic strategies that target the cellular transformation process for ca...
Therapeutic strategies that target the cellular transformation process for ca...
 
STaRS Poster Final
STaRS Poster FinalSTaRS Poster Final
STaRS Poster Final
 
Duzkale_2011_CLL biomarker LDOC1
Duzkale_2011_CLL biomarker LDOC1Duzkale_2011_CLL biomarker LDOC1
Duzkale_2011_CLL biomarker LDOC1
 
Project proposal from venkatesh (bt)
Project proposal from venkatesh (bt)Project proposal from venkatesh (bt)
Project proposal from venkatesh (bt)
 
Molecular target therapy_in_colorectal_cancer[1]
Molecular target therapy_in_colorectal_cancer[1]Molecular target therapy_in_colorectal_cancer[1]
Molecular target therapy_in_colorectal_cancer[1]
 
Genetic Markers in AML
Genetic Markers in AMLGenetic Markers in AML
Genetic Markers in AML
 
Cancer genes
Cancer genesCancer genes
Cancer genes
 

Yang Poster 2015

  • 1. Prediction of Gene Signatures in TGFB-induced Breast Cancer Metastasis by Markov Chain Model Yang Cong, Shenyi Chen, Stephen T.C. Wong Department of Systems Medicine and Bioengineering, Houston Methodist Research Institute, 6670 Berter Ave, Houston, TX 77030 Abstract Introduction TGFB-EMT pathway CDH1 transcription factor selection Expression Signature Prediction Results Acknowledgements •NCI Center for Modeling Cancer Development U54 Ca149196 Metastasis is a major cause of patient death in breast cancer. Epithelial-mesenchymal transition (EMT) plays the initiation role in the metastasis cascade. Based on gene profiling data of 1165 breast cancer patients in TCGA, we built a statistical Markov Chain model to predict gene signatures of epithelial and mesenchymal cells. Based on the literature integrated TGFB-induced EMT pathway, we extracted the regulatory mechanism among molecules. We used a recursive algorithm to predict the likelihood of expression signatures and further mapped the prediction with known epithelial and mesenchymal expression patterns. A molecule is regulated by its regulators, and the change of its expression level only depends on the observed expression of all its regulators The loss of the epithelial adhesion molecule E-cadherin (CDH1) is considered as a fundamental event in EMT and an early step in cancer metastasis. EMT can be induced by several growth factors, such as TGFB1, hepatocyte growth factor, and platelet-derived growth factor PDGF. Also EMT can be induced by any one of the following transcription factors alone, such as SNAI1, SNAI2, TWIST1, FOXC1, FOXC2, ZEB1 and ZEB2. A central target of these transcription factors listed above is the repression of E-cadherin gene CDH1. The expression level of CDH1 plays a key role in the cell phenotype. The inhibition of CDH1 expression is the starter of EMT process. Epithelial cells have a high expression level of CDH1, meanwhile mesenchymal cells have a low expression. Hence, we map the expression patterns with cell types based on the expression level of CDH1. Data Processing